These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8561983)

  • 1. Tolerance of a triple combination therapy with zidovudine, didanosine and interferon-alpha in seven HIV-infected patients.
    Bissuel F; Trabaud MA; Leriche K; Cotte L; Schlienger I; Rougier P; Trepo C
    AIDS; 1995 Nov; 9(11):1285. PubMed ID: 8561983
    [No Abstract]   [Full Text] [Related]  

  • 2. D4T nucleoside combinations for HIV.
    Pollard RB
    Antiviral Res; 1996 Jan; 29(1):101-4. PubMed ID: 8721558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment by antiviral drugs of HIV-infected patients].
    Mayaud C
    Rev Pneumol Clin; 1993; 49(2):71-4. PubMed ID: 8272744
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
    Montaner JS; Reiss P; Cooper D; Vella S; Harris M; Conway B; Wainberg MA; Smith D; Robinson P; Hall D; Myers M; Lange JM
    JAMA; 1998 Mar; 279(12):930-7. PubMed ID: 9544767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial.
    Kovacs JA; Bechtel C; Davey RT; Falloon J; Polis MA; Walker RE; Metcalf JA; Davey V; Piscitelli SC; Baseler M; Dewar R; Salzman NP; Masur H; Lane HC
    J Infect Dis; 1996 Apr; 173(4):840-8. PubMed ID: 8603961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of syncytium-inducing HIV-1 strains during therapy with zidovudine alone or combined with alpha interferon or didanosine.
    Torres Y; Leal M; Rey C; Medrano FJ; Sánchez-Quijano A; Lissen E
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):324-7. PubMed ID: 8781884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of combination therapy confirmed.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy increases survival.
    Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals plus immunomodulators: didanosine/interferon-alpha combination shows promise.
    Folkers G
    NIAID AIDS Agenda; 1996 Jun; ():8-9. PubMed ID: 11363810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study results at a glance.
    AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
    Simonelli C; Zanussi S; Comar M; Vaccher E; Giacca M; De Paoli P; Tirelli U
    AIDS; 1998 Jan; 12(1):112-3. PubMed ID: 9456263
    [No Abstract]   [Full Text] [Related]  

  • 13. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):7. PubMed ID: 11363052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on clinical trials of combination therapies for HIV infection.
    NIAID AIDS Agenda; 1995 Sep; ():8. PubMed ID: 11362803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination drug treatment benefits patients with HIV.
    Boulton A
    BMJ; 1996 Aug; 313(7053):320. PubMed ID: 8760735
    [No Abstract]   [Full Text] [Related]  

  • 16. 3TC: combination trial stopped early as clinical benefit shown.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent therapy.
    Volberding PA
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):454-6. PubMed ID: 8158538
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of combining zidovudine plus didanosine in patients with and without previous exposure to zidovudine].
    Gómez-Cano M; Soriano V; García-Lerma G; González-Lahoz J
    An Med Interna; 1998 Mar; 15(3):145-7. PubMed ID: 9567422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
    Mildvan D; Bassiakos Y; Zucker ML; Hyslop N; Krown SE; Sacks HS; Zachary J; Paredes J; Fessel WJ; Rhame F; Kramer F; Fischl MA; Poiesz B; Wood K; Ruprecht RM; Kim J; Grossberg SE; Kasdan P; Bergé P; Marshak A; Pettinelli C
    Antivir Ther; 1996 Apr; 1(2):77-88. PubMed ID: 11321183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.